IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lynx1 Capital Management LP

Q4 2024 Holdings

Filed 2025-02-14 | 18 holdings | $266.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Merus N VCOMN5749R100$66.5M1,580,84124.9%
Stoke Therapeutics Inc(STOK)COM86150R107$57.2M5,187,19121.5%
GH Research PLC(GHRS)ORDINARY SHARESG3855L106$34.0M4,858,99412.8%
C4 Therapeutics Inc(CCCC)COM STK12529R107$24.7M6,852,7449.2%
Allogene Therapeutics Inc(ALLO)COM019770106$23.2M10,874,7238.7%
Tscan Therapeutics Inc(TCRX)COM89854M101$16.3M5,357,3476.1%
Cullinan Therapeutics Inc(CGEM)COM230031106$15.3M1,257,7955.7%
Keros Therapeutics Inc(KROS)COM492327101$8.6M544,0013.2%
Passage BIO IncCOM702712100$5.2M9,256,9532.0%
Allakos Inc(ALLKGUSD)COM01671P100$4.4M3,628,1441.6%
Upstream BIO Inc(UPB)COM91678A107$3.9M240,0421.5%
Precision Biosciences Inc(DTIL)COM NEW74019P207$2.9M766,0511.1%
Ibio Inc(IBIO)CON NEW451033708$2.1M862,2790.8%
Caribou Biosciences Inc(CRBU)COM142038108$1.1M680,1890.4%
VOR Biopharma IncCOM929033108$707.3K637,2180.3%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$291.5K17,4000.1%
Neuphoria Therapeutics Inc(NEUP)COM64136E102$157.1K45,8060.1%
Repare Therapeutics Inc(RPTX)COM760273102$103.7K79,1760.0%